MONTELUKAST Safety Questions, MONTELUKAST Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about MONTELUKAST. Our extensive database of MONTELUKAST adverse events and MONTELUKAST warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about MONTELUKAST
MONTELUKAST Safety Reports
Total MONTELUKAST reports: 11.MONTELUKAST FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 6.
Take MONTELUKAST Side Effects Survey or Share Your MONTELUKAST Story. Read More Here.
Consumer or non-health professional from JAPAN reported MONTELUKAST problem on Apr 26, 2007. Female patient, 48 years of age, weighting 145.0 lb, was diagnosed with asthma and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: asthma, body temperature decreased, chills, heart rate increased, pyrexia, white blood cell count increased. MONTELUKAST dosage: 7 MG;DAILY;IV. During the same period patient was treated with SUMILU, CHLORIDE. Patient was hospitalized. Patient recovered.
MONTELUKAST problem was reported by a Pharmacist from UNITED STATES on May 22, 2007. Male patient, 56 years of age, was diagnosed with asthma, hypersensitivity, schizophrenia, paranoid type and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: allergic granulomatous angiitis. MONTELUKAST dosage: 10MG EVERY DAY PO. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported MONTELUKAST problem on May 29, 2007. Male patient, 57 years of age, was diagnosed with asthma and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: alcohol use, anaemia haemolytic autoimmune, dyspnoea at rest, hepatomegaly, jaundice, ocular icterus, oedema peripheral, oxygen saturation decreased, respiratory rate increased. MONTELUKAST dosage: 10 MG ONCE DAILY PO. During the same period patient was treated with ZAFIRLUKAST, ALPRAZOLAM, AMLODIPINE, NABUMETONE. Patient was hospitalized. Patient recovered.
MONTELUKAST problem was reported by a Physician from PORTUGAL on July 04, 2006. Male patient, 40 years of age, was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: skin reaction. MONTELUKAST dosage: unknown. Patient recovered.
Physician from UNITED KINGDOM reported MONTELUKAST problem on Aug 17, 2006. Female patient, 35 years of age, was diagnosed with asthma and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. MONTELUKAST dosage: unknown. During the same period patient was treated with ALBUTEROL, FLUTICASONE PROPIONATE, SALMETEROL. Patient recovered.
MONTELUKAST problem was reported by a Physician from UNITED STATES on Sept 26, 2006. Female patient, 41 years of age, weighting 280.0 lb, was diagnosed with rhinitis allergic and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, hepatitis cholestatic, nephrolithiasis, thrombocytopenia, urinary tract infection, white blood cell count increased. MONTELUKAST dosage: 10 MG QHS PO. During the same period patient was treated with LORATADINE, FLUTICASONE PROPIONATE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
Physician from PORTUGAL reported MONTELUKAST problem on Oct 30, 2006. Female patient, child 7 years of age, was diagnosed with asthma and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: diplopia, eye disorder, headache, intracranial pressure increased. MONTELUKAST dosage: unknown. Patient recovered.
MONTELUKAST problem was reported by a Physician from PORTUGAL on Oct 30, 2006. Female patient, child 7 years of age, was diagnosed with asthma and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: diplopia, eye disorder, headache, intracranial pressure increased. MONTELUKAST dosage: unknown. Patient recovered.
Physician from VENEZUELA reported MONTELUKAST problem on Nov 15, 2006. Female patient, child 5 years of age, was diagnosed with asthma and was treated with MONTELUKAST. MONTELUKAST dosage: unknown. During the same period patient was treated with BUDESONIDE. Patient died.
MONTELUKAST problem was reported by a Physician from JAPAN on Sept 05, 2007. Male patient, 15 years of age, was diagnosed with asthma and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. MONTELUKAST dosage: unknown. During the same period patient was treated with ZYRTEC. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported MONTELUKAST problem on Sept 11, 2007. Male patient, 15 years of age, was diagnosed with asthma, dermatitis atopic and was treated with MONTELUKAST. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. MONTELUKAST dosage: unknown. During the same period patient was treated with ZYRTEC. Patient was hospitalized. Patient recovered.
This
drug has an active FDA Safety Alert